The United States Drug-Eluting Stent Market holds the dominant share within North America due to the country’s high burden of cardiovascular disorders and well-established cardiac care infrastructure. Increasing volumes of angioplasty procedures, growing awareness regarding advanced coronary artery disease treatment options, and rising adoption of minimally invasive cardiovascular...